Frenchman sues Glaxo over drug that made him 'sex addict'

Jan 31, 2011

A French father-of-two is to take GlaxoSmithKline to court on Tuesday, alleging the British firm's drug to treat Parkinson's disease turned him into a gay sex and gambling addict.

The 51-year-old's lawyers say their client's behaviour changed radically after he was first administered the drug in 2003 for the illness, which causes tremors, slows movement and disrupts speech.

Didier Jambart, a married father-of-two who says he has attempted suicide three times, claims he became addicted to , losing the family's savings and stealing to feed his habit.

He also became a compulsive gay sex addict and began exposing himself on the Internet and cross-dressing. His risky sexual encounters led to him being raped, his lawyers said.

The behaviour stopped when he stopped taking the drugs in 2005 but by then he had been demoted in his defence ministry job and was suffering from psychological trauma resulting from his addictions, his lawyers said.

The plaintiff is seeking a total of 450,000 euros ($610,000) in damages from Glaxo, which he accuses of selling a "defective" drug, and from his neurologist for having failed to properly inform him about the drug.

The drug, Requip, has been known for years to have undesired side effects but a warning only appeared on its package insert in 2006, his lawyers said.

Glaxo said it did not wish to comment on the case.

Explore further: Rapivab approved to help treat flu

add to favorites email to friend print save as pdf

Related Stories

FDA questions safety of Glaxo kidney cancer drug

Oct 01, 2009

(AP) -- Federal regulators said Thursday an experimental kidney cancer drug from GlaxoSmithKline may cause liver problems, potentially outweighing its ability to slow the disease.

Recommended for you

Express Scripts turns to AbbVie in huge hepatitis C deal

10 hours ago

The nation's largest pharmacy benefits manager is throwing its weight into the fight over high-cost hepatitis C drugs with a coverage restriction that might ultimately lower prices and improve patient access ...

FDA OKs Cubist antibiotic for serious infections

Dec 20, 2014

The Food and Drug Administration has approved a new medicine to fight complex infections in the abdomen and urinary tract, the fourth antibiotic the agency has approved since May.

Xtoro approved for swimmer's ear

Dec 18, 2014

(HealthDay)—Xtoro (finafloxacin otic suspension) eardrops have been approved by the U.S. Food and Drug Administration to treat swimmer's ear, clinically known as acute otitis externa.

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

NickFun
not rated yet Jan 31, 2011
Could it be he had these tendencies to begin with?

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.